Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Systemic T-cell unresponsiveness during rush bee-venom immunotherapy

J A Segura1, M Assenmacher, J Irsch

  • 1Institute for Genetics, University of Cologne, Germany.

Allergy
|May 23, 1998
PubMed
Summary

Rush immunotherapy for bee venom allergy desensitizes patients by reducing T cell responses. Most allergic individuals show decreased T cell activation markers and cytokines, unlike normal donors, indicating treatment effectiveness.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Preventive effects of early immunosuppressive treatment on the development of interstitial lung disease in systemic sclerosis.

Rheumatology (Oxford, England)·2024
Same author

Influence of an allogenic collagen scaffold on implant sites with thin supracrestal tissue height: a randomized clinical trial.

Clinical oral investigations·2024
Same author

Consensus statement on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: Localized scleroderma, systemic sclerosis and overlap syndromes.

Journal of the European Academy of Dermatology and Venereology : JEADV·2024
Same author

[Systemic sclerosis].

Dermatologie (Heidelberg, Germany)·2024
Same author

Automated Detection of Cerebral Aneurysms on TOF-MRA Using a Deep Learning Approach: An External Validation Study.

AJNR. American journal of neuroradiology·2022
Same author

[How I treat calcinosis cutis in the context of collagenosis…].

Zeitschrift fur Rheumatologie·2021

Area of Science:

  • Immunology
  • Allergy Research
  • T cell biology

Background:

  • Rush bee-venom immunotherapy effectively desensitizes allergic individuals.
  • The underlying immunological mechanisms of this desensitization remain largely unknown.
  • Understanding T cell responses is crucial for elucidating immunotherapy's effects.

Purpose of the Study:

  • To investigate the systemic effects of rush bee-venom immunotherapy on T cells in allergic patients.
  • To analyze changes in T cell activation markers and cytokine production during immunotherapy.
  • To differentiate T cell responses between allergic patients and healthy individuals.

Main Methods:

  • Analysis of T cell populations, including CD69, IL-4, IFN-gamma, and IL-2 expression.
  • Stimulation of peripheral blood mononuclear cells (PBMCs) using phorbol 12-myristate 13-acetate (PMA) and ionomycin.

Related Experiment Videos

  • Comparison of T cell responses in allergic patients undergoing immunotherapy versus normal donors.
  • Assessment of cytokine expression in CD45RO+ and CD45RO- T cell subsets.

    • Main Results:

    • Most allergic patients showed reduced frequencies of T cells expressing CD69, IL-4, and IFN-gamma after stimulation, which decreased further during immunotherapy.
    • A subset of patients exhibited unchanged frequencies of CD69, IL-4, and IFN-gamma, but increased IL-2 expression.
    • Allergic patients, particularly in the CD45RO- T cell population, displayed higher IL-4 and IFN-gamma frequencies compared to normal donors, a difference not altered by immunotherapy.
    • Most allergic patients' T cells became unresponsive to mitogenic stimulation, suggesting a role in desensitization.

    Conclusions:

    • Rush bee-venom immunotherapy induces desensitization, primarily by reducing T cell activation and cytokine production in most allergic patients.
    • Heterogeneity exists in patient responses, with some showing increased IL-2 production.
    • Distinct T cell cytokine profiles, especially in CD45RO- T cells, differentiate allergic patients from controls, irrespective of immunotherapy status.